A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Clinical trial NCT06692283 · WITHDRAWN

Trial details

NCT number: NCT06692283
Sponsor: Sagimet Biosciences Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

MASLD MASH NASH Metabolic Dysfunction-Associated Steatotic Liver Disease Metabolic Dysfunction-Associated Steatohepatitis Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver

Start date: 2025-03-01
Primary completion: 2026-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.